Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas

被引：97
|
作者：
Kelaidi, C
Rollot, F
Park, S
Tulliez, M
Christoforov, B
Calmus, Y
Podevin, P
Bouscary, D
Sogni, P
Blanche, P
Dreyfus, F
机构：
[1] Univ Paris 05, Hop Cochin, Dept Hematol, Assistance Publ Hop Paris, F-75014 Paris, France
[2] Univ Paris 05, Hop Cochin, Dept Internal Med 2, Assistance Publ Hop Paris, Paris, France
[3] Univ Paris 05, Hop Cochin, Dept Anat Pathol, Assistance Publ Hop Paris, Paris, France
[4] Univ Paris 05, Hop Cochin, Dept Internal Med 1, Assistance Publ Hop Paris, Paris, France
[5] Univ Paris 05, Hop Cochin, Dept Surg & Liver Transplantat, Assistance Publ Hop Paris, Paris, France
[6] Univ Paris 05, Hop Cochin, Dept Hepatogastroenterol, Assistance Publ Hop Paris, Paris, France
来源：
LEUKEMIA | 2004年 / 18卷 / 10期
关键词：
hepatitis C virus; marginal zone lymphoma; splenic lymphoma with villous lymphocytes; interferon; ribavirin; large granular lymphocyte leukemia;
D O I：
10.1038/sj.leu.2403443
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A link between chronic hepatitis C virus (HCV) infection and low-grade B-cell lymphomas has been suggested by epidemiological studies. Marginal zone lymphomas (MZLs) including splenic lymphomas with villous lymphocytes are among the most frequently reported subgroups in the setting of chronic HCV infection. In this study, we examined the effect of antiviral treatment in eight patients with HCV-associated MZL. We found that five out of eight patients have responded to interferon alpha and ribavirin. In some cases, hematologic responses were correlated to virologic responses. In addition, we report a case of large granular lymphocyte leukemia occurring in association with MZL and HCV, and responding to interferon and ribavirin. We suggest that there is an etiologic link between HCV and antigen-driven lymphoproliferative disorders.
引用
收藏
页码：1711 / 1716
页数：6
相关论文
共 50 条
  • [1] Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas
    C Kelaidi
    F Rollot
    S Park
    M Tulliez
    B Christoforov
    Y Calmus
    P Podevin
    D Bouscary
    P Sogni
    P Blanche
    F Dreyfus
    Leukemia, 2004, 18 : 1711 - 1716
  • [2] Hepatitis C Virus Infection and Antiviral Treatment in Marginal Zone Lymphomas
    Arcaini, Luca
    Bruno, Raffaele
    CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (02): : 74 - 81
  • [3] Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis
    Soresi, M.
    Tripi, S.
    Franco, V.
    Giannitrapani, L.
    Alessandri, A.
    Rappa, F.
    Vuturo, O.
    Montalto, G.
    LIVER INTERNATIONAL, 2006, 26 (09) : 1119 - 1125
  • [4] Marginal-zone lymphomas: clinical correlation and treatment results with and without of hepatitis C virus
    Lepkov, S.
    Subortceva, I.
    Tumian, G.
    Zacharov, O.
    Ivanova, V.
    Kokosadze, N.
    Kolomiytcev, O.
    Ribuchina, J.
    Borisovskay, S.
    Padjeva, T.
    Ivachenco, R.
    Kuprichina, N.
    Lazarev, I.
    Ettinger, O.
    Komarov, I.
    Zeynalova, P.
    Kovrigina, A.
    Nikitin, I.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 173 - 173
  • [5] Hepatitis C virus - Associated marginal zone lymphoma
    Armand, Marine
    Besson, Caroline
    Hermine, Olivier
    Davi, Frederic
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (1-2) : 41 - 49
  • [6] Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy
    Mazzaro, Cesare
    Bomben, Riccardo
    Gragnani, Laura
    Visentini, Marcella
    Pozzato, Gabriele
    Pozzo, Federico
    Zucchetto, Antonella
    Gattei, Valter
    SEMINARS IN HEMATOLOGY, 2022, 59 (04) : 177 - 182
  • [7] Hepatitis C virus infection (and additional neoplasms) among marginal zone lymphomas
    Silvestri, F
    Barillari, G
    Fanin, R
    Salmaso, F
    Infanti, L
    Zaja, F
    Baccarani, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (02) : 427 - 428
  • [8] Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN
    Alric, L
    Plaisier, E
    Théault, S
    Péron, JM
    Rostaing, L
    Pourrat, J
    Ronco, P
    Piette, JC
    Cacoub, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : 617 - 623
  • [9] Treatment of Hepatitis C Virus-Associated Mixed Cryoglobulinemia with Direct-Acting Antiviral Agents
    Sise, Meghan E.
    Bloom, Allyson K.
    Wisocky, Jessica
    Lin, Ming V.
    Gustafson, Jenna L.
    Lundquist, Andrew L.
    Steele, David
    Thiim, Michael
    Williams, Winfred W.
    Hashemi, Nikroo
    Kim, Arthur Y.
    Thadhani, Ravi
    Chung, Raymond T.
    HEPATOLOGY, 2016, 63 (02) : 408 - 417
  • [10] Is Hepatitis B Virus-Associated Intrahepatic Cholangiocarcinoma Preventable With Antiviral Treatment?
    Tanaka, Atsushi
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 821 - 822
12345